🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-13
Trial ID
NCT07645209
Treatments Being Tested
This is a prospective, single-center, single-arm, open-label clinical study...
Status
Unknown
Location
Beijing Friendship Hospital
Start Date
2018-01-01
Trial ID
NCT04345783
Treatments Being Tested
This is a prospective, single-arm, single-center, clinical research.This tr...
Status
Unknown
Location
Multiple Locations
Start Date
2021-05-06
Trial ID
NCT04850040
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of simple...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2019-11-01
Trial ID
NCT04204577
Treatments Being Tested
This is a phase II, open-labeled, multi-centered,single-arm, Investigator-i...
Status
Unknown
Location
The First Affiliated Hospital, Sun Yat-Sen University
Start Date
2020-03-25
Trial ID
NCT04303741
Treatments Being Tested
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-06-15
Trial ID
NCT05313282
The purpose of this study is to evaluate the efficacy and safety of Apatini...
Status
Unknown
Location
Zhongnan Hopital of Wuhan University
Start Date
2021-05-14
Trial ID
NCT04781686
Treatments Being Tested
This study is a multicenter, single-arm, phase II exploratory study, aims t...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2025-01-15
Trial ID
NCT06759090
Treatments Being Tested
Apatinib and SHR-1210 are new drugs produced by jiangsu hengrui pharmaceuti...
Status
Unknown
Location
Beijing Hospital
Start Date
2021-03-25
Trial ID
NCT04832204
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of camreli...
Status
Completed
Location
Sun Yat-sen University
Start Date
2020-04-25
Trial ID
NCT04366128
Treatments Being Tested